Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 56.98
+0.17 (0.30%)
Apr 17, 2026, 3:04 PM CST
SHE:300049 Market Cap
SHE:300049 has a market cap or net worth of 15.1 billion as of April 17, 2026. Its market cap has increased by 66.08% in one year.
Market Cap
15.10B
Enterprise Value
14.95B
Revenue
1.60B
Ranking
n/a
PE Ratio
98.24
Stock Price
56.98
Market Cap Chart
Since January 20, 2010, SHE:300049's market cap has increased from 2.54B to 15.10B, an increase of 495.02%. That is a compound annual growth rate of 11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 15.10B | -19.07% |
| Dec 31, 2025 | 18.66B | 122.08% |
| Dec 31, 2024 | 8.40B | -26.74% |
| Dec 29, 2023 | 11.47B | 78.43% |
| Dec 30, 2022 | 6.43B | 70.55% |
| Dec 31, 2021 | 3.77B | 80.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 16.45B |
| Jinyu Bio-technology | 16.04B |
| Mabwell (Shanghai) Bioscience | 15.45B |
| Staidson (Beijing) BioPharmaceuticals | 14.49B |
| Tibet Cheezheng Tibetan Medicine | 13.27B |
| Chengzhi | 12.97B |
| Vcanbio Cell & Gene Engineering Corp., | 12.91B |
| InventisBio | 12.76B |